These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 738902)

  • 1. Further studies on lymphocyte beta-glucuronidase abnormality in cystic fibrosis. Possible relations to carboxypeptidase B-like activity.
    Marchi AG; Marchi MA; Cigui I; Uxa F; Perticarari S; Nordio S
    Helv Paediatr Acta; 1978 Dec; 33(6):517-25. PubMed ID: 738902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proceedings: Study of beta-glucuronidase in lymphocytes cultivated in vitro in cystic fibrosis].
    Mangiarotti Marchi MA; Marchi AG; Mastella G; Nordio S
    Quad Sclavo Diagn; 1973 Mar; 9(1):484-9. PubMed ID: 4788726
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enzymatic lysosomal activity in phyto-stimulated lymphocytes in cystic fibrosis of the pancreas. A new test for screening of heterozygotes?].
    Marchi AG; Mangiarotti Marchi MA; Nordio S
    Minerva Pediatr; 1971 Nov; 23(44):1842-6. PubMed ID: 5163021
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of human leukocyte degranulation induced by sera from homozygotes and heterozygotes for cystic fibrosis.
    Conod EJ; Conover JH; Hirschhorn K
    Pediatr Res; 1975 Sep; 9(9):724-9. PubMed ID: 172851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal beta-glucuronidase activity in cystic fibrosis.
    Marchi AG; Marchi MA; Mastella G; Nordio S
    Helv Paediatr Acta; 1973 Nov; 28(5):427-35. PubMed ID: 4773224
    [No Abstract]   [Full Text] [Related]  

  • 6. Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride.
    Witko-Sarsat V; Allen RC; Paulais M; Nguyen AT; Bessou G; Lenoir G; Descamps-Latscha B
    J Immunol; 1996 Sep; 157(6):2728-35. PubMed ID: 8805680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of serum amylase isoenzymes in cystic fibrosis homozygotes and heterozygotes.
    Takács O; Sohár I; László A; Pénzes P; Gyurkovits K
    Acta Paediatr Acad Sci Hung; 1977; 18(1):21-6. PubMed ID: 602748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal response of cultured lymphocytes to phytohemagglutinin and autologous serum in cystic fibrosis.
    Lieberman J; Kaneshiro W
    Am Rev Respir Dis; 1977 Dec; 116(6):1047-55. PubMed ID: 931181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis. In vitro and in vivo studies on the biochemical background to the pathogenesis.
    Ceder O
    Acta Paediatr Scand Suppl; 1983; 309():1-47. PubMed ID: 6581681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytic acid-hydrolases and response to mitogens in cystic fibrosis.
    Lieberman J; Kaneshiro W
    Chest; 1979 Feb; 75(2 Suppl):220-3. PubMed ID: 108048
    [No Abstract]   [Full Text] [Related]  

  • 11. Carboxypeptidase B-like activity and C3 in cystic fibrosis.
    Lieberman J
    Am Rev Respir Dis; 1975 Jan; 111(1):100-2. PubMed ID: 803353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on cystic fibrosis using isoelectric focusing. III. Correlation between cystic fibrosis protein and ciliary dyskinesia activity in serum shown by a modified rabbit tracheal bioassay.
    Wilson GB; Monsher MT; Fudenberg HH
    Pediatr Res; 1977 Feb; 11(2):143-6. PubMed ID: 840504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of a serum hemagglutinin (lectinlike factor) in cystic fibrosis homozygotes and heterozygotes.
    Lieberman J; Kaneshiro W; Costea NV
    J Lab Clin Med; 1981 May; 97(5):646-53. PubMed ID: 7217767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of serum carboxypeptidase B-like (anaphylatoxin inactivator, carboxypeptidase N) activity in sera from patients with cystic fibrosis.
    Koheil A; Corey M; Forstner G
    Clin Invest Med; 1979; 2(2-3):99-103. PubMed ID: 533638
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory role of lysosomal enzymes in rat lymphocyte reactivity in vitro.
    Ryzewska A; Zukowska M; Karpowicz E; Brajczewska-Fiszer W
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):337-40. PubMed ID: 6457581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis. Carbohydrate metabolism in CF and in animal models for CF.
    Bardoń A
    Acta Paediatr Scand Suppl; 1987; 332():1-30. PubMed ID: 3474861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of cystic fibrosis heterozygotes using the zeta potential reduction method.
    Litt M; Khan MA
    Tex Rep Biol Med; 1976; 34(1):151-4. PubMed ID: 996785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis: present status and future prospects in detection of patients and carriers.
    Forstner G; Crozier DN; Sturgess JM
    Can Med Assoc J; 1975 Sep; 113(6):550-6. PubMed ID: 1156983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis heterozygotes do not have increased platelet activation.
    Tarnow I; Michelson AD; Frelinger AL; Linden MD; Li Y; Fox ML; Barnard MR; O'Sullivan BP
    Thromb Res; 2007; 121(2):159-62. PubMed ID: 17532368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polyamines and cystic fibrosis serum on glucose transport.
    Arvanitakis S; Mangos J; McSherry NR; Rennert O
    Tex Rep Biol Med; 1976; 34(1):175-86. PubMed ID: 996787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.